Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 8/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | DAO | P14920 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.53 |
| ▸ | FBP1 | P09467 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15769072 | 1.00 | SRD5A2 (0.75) | SRD5A2ALDH1A1DAOTSHRNAPRT | |
| SCHEMBL15768763 | 0.94 | ALDH1A1 (0.67) | SRD5A2ALDH1A1CES2CES1HDAC1 | |
| SCHEMBL15768764 | 0.94 | ALDH1A1 (0.67) | SRD5A2ALDH1A1CES2CES1HDAC1 | |
| SCHEMBL1405641 | 0.91 | HDAC1 (0.64) | SRD5A2ALDH1A1HDAC1CYP2C9TTR | |
| SCHEMBL1405644 | 0.91 | HDAC1 (0.64) | SRD5A2ALDH1A1HDAC1CYP2C9TTR | |
| SCHEMBL27792692 | 0.89 | HDAC1 (0.67) | SRD5A2ALDH1A1HDAC1CYP2C9CYP2D6 | |
| SCHEMBL8437189 | 0.89 | HDAC1 (0.67) | SRD5A2ALDH1A1DAOTSHRNAPRT | |
| SCHEMBL1927732 | 0.89 | HDAC1 (0.67) | SRD5A2ALDH1A1DAOTSHRNAPRT | |
| SCHEMBL1927729 | 0.89 | HDAC1 (0.67) | SRD5A2ALDH1A1DAOTSHRNAPRT | |
| SCHEMBL11545296 | 0.89 | HDAC1 (0.67) | SRD5A2ALDH1A1DAOTSHRNAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9629945-B2 | Stilbene-based reactive compounds, polymeric matrices formed therefrom, and articles visualizable by fluorescence | SURMODICS, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| US-20140162083-A1 | STILBENE-BASED REACTIVE COMPOUNDS, POLYMERIC MATRICES FORMED THEREFROM, AND ARTICLES VISUALIZABLE BY FLUORESCENCE | SURMODICS, INC. (US) | 2014-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140162083-A1 | STILBENE-BASED REACTIVE COMPOUNDS, POLYMERIC MATRICES FORMED THEREFROM, AND ARTICLES VISUALIZABLE BY FLUORESCENCE | ITK, NOTUM, ITGAM | SRD5A2 4160/4885ALDH1A1 1967/4885DAO 1500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.